Stay updated on Pembrolizumab CNS Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.

Latest updates to the Pembrolizumab CNS Metastases Clinical Trial page
- Check3 days agoChange DetectedThe page now shows a Revision: v3.5.5 tag, replacing the previous v3.5.4 tag, indicating the current software version powering the site.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.5.4 replaces the previous v3.5.3 on the study page. This represents a minor site build update to the rendering template used for the record, with no change to the study data.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check53 days agoChange DetectedSystem revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check83 days agoChange DetectedVersion update from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check90 days agoChange DetectedResults Submitted appears, replacing No Results Posted. The page revision has been updated to v3.4.3 from v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab CNS Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.